Lisamarie A. Collins

Senior Counsel


Lisamarie Collins, Ph.D., is a senior counsel and intellectual property lawyer with Foley & Lardner LLP. She is a member of the Chemical, Biotechnology & Pharmaceutical Practice and the Life Sciences Industry Team.

In 2012, Dr. Collins served as a summer associate and later as a law clerk with Foley. Earlier she also worked as a law clerk with the Wisconsin State Department of Corrections. Prior to her legal career, she gained research and teaching experience in physiological and biological sciences at the Medical College of Wisconsin and Marquette University.


Dr. Collins earned her law degree from Marquette University Law School (J.D., magna cum laude, 2013), where she served as editor-in-chief of the Marquette Intellectual Property Law Review. She has a Ph.D. in physiology from the Medical College of Wisconsin (2010). Dr. Collins has an honors B.S. in biomedical sciences and a secondary major in French from Marquette University (summa cum laude, 2005) and was a member of Phi Beta Kappa, Alpha Sigma Nu, and Pi Delta Phi honor societies.

Admissions and Professional Memberships

Dr. Collins is a member of the Intellectual Property Law Section of the State Bar of Wisconsin. She is admitted to practice in Wisconsin and before the United States Patent and Trademark Office.


  • Co-author, “LDT Proposals: Concerns about the FDA’s proposal LDT regulations on test providers and patients,” Advanced Healthcare Network for Laboratory (March 14, 2016)
  • Co-author, “Laboratory Developed Tests (LDTs) – An emerging area of FDA regulation,” Advance Healthcare Network for Laboratory (December 28, 2015)
  • Author, “Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?” BNA Bloomberg 210 (October 30, 2015)
  • Author, "Copyrightable Works in the Undergraduate Student Context: An Examination of the Issues," Marquette Intellectual Property Law Review, 285 (2013).
  • Co-author, "Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry," Physiol Genomics, 40: 208-215, 2010.
  • Co-author, "Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry," Proteome Science, 8:42, 2010.